Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Planned sale Chief Financial Officer sold 672 shares at $32.57 ($21,887)
  2. 4 Planned sale Principal Accounting Officer sold 1,214 shares at $32.57 ($39,540)
  3. 4 Planned sale Chief Executive Officer sold 4,156 shares at $32.57 ($135,361)
  4. 4 Planned sale Chief Legal Officer sold 2,642 shares at $32.57 ($86,050)
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Director sold 69,329 shares at an average $34.67 ($2,403,592)
  7. 4 Open-market sale Director sold 68,142 shares at an average $33.09 ($2,254,951)
  8. 4 Open-market sale Principal Accounting Officer sold 504 shares at $26.63 ($13,422)
  9. 4 Planned sale Chief Medical Officer sold 642 shares at $25.14 ($16,140)
  10. 4 Planned sale Chief Legal Officer sold 545 shares at $25.14 ($13,701)
  11. 4 Planned sale Principal Accounting Officer sold 273 shares at $25.14 ($6,863)
  12. 4 Planned sale Chief Legal Officer sold 1,708 shares at $21.64 ($36,961)
  13. 4 Planned sale Chief Medical Officer sold 1,708 shares at $21.64 ($36,961)
  14. 4 Planned sale Chief Financial Officer sold 1,886 shares at $21.64 ($40,813)
  15. 4 Planned sale Director sold 10,722 shares at $21.64 ($232,024)
  16. 4 Planned sale Chief Executive Officer sold 7,635 shares at $21.64 ($165,221)
  17. 4 Planned sale Chief Commercial Officer sold 1,618 shares at $21.64 ($35,014)
  18. 4 Planned sale Chief Executive Officer sold 12,066 shares at $22.99 ($277,397)
  19. 4 Planned sale Director sold 8,391 shares at $22.99 ($192,909)
  20. 4 Planned sale Chief Legal Officer sold 1,163 shares at $22.99 ($26,737)

Page 7 of 38 · 758 filings